Morgan Sheng
Corporate Officer/Principal bei Massachusetts Institute of Technology
Aktive Positionen von Morgan Sheng
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Massachusetts Institute of Technology | Corporate Officer/Principal | - | - |
Karriereverlauf von Morgan Sheng
Ehemalige bekannte Positionen von Morgan Sheng
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PREVAIL THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 15.11.2019 | 22.01.2021 |
| Independent Dir/Board Member | 15.11.2019 | 22.01.2021 | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 15.09.2008 | - |
Ausbildung von Morgan Sheng
| University of Oxford | Undergraduate Degree |
| University of London | Doctorate Degree |
| Harvard University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Vereinigtes Königreich | 3 |
Operativ
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY. | Health Technology |
- Börse
- Insiders
- Morgan Sheng
- Erfahrung
